Abstract
Thyroid cancer (TC) cases are not just a local concern, but a global issue on the rise. This necessitates a thorough evaluation of existing diagnostic methods. TC diagnosis adheres to the American Thyroid Association's recommendations, which involve laboratory testing, fine needle aspirate cytology, and biopsy. Ultrasonography, MRI, Positron Emission Tomography (PET), and CT scans are also essential in the diagnostic process. The measurement of serum TSH is critical for diagnosing several conditions, while the measurement of serum calcitonin assists in diagnosing medullary thyroid cancer. Recent advancements in the field have included molecular testing methods such as ThyroSeq and Afirma assays. These tests effectively minimize the necessity for diagnostic surgery and enhance diagnostic precision, indicating a significant change in thyroid cancer therapy toward improved patient outcomes.
| Original language | English |
|---|---|
| Title of host publication | Diagnostic Landscape in Cancer Research |
| Publisher | Elsevier |
| Pages | 235-246 |
| Number of pages | 12 |
| ISBN (Electronic) | 9780443338496 |
| ISBN (Print) | 9780443338502 |
| DOIs | |
| Publication status | Published - 1 Jan 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Calcitonin
- Diagnosis
- Fine needle aspirate
- Molecular
- Positron emission tomography
- Thyroid cancer
- Thyroid stimulating hormone
- Ultrasound scan
Fingerprint
Dive into the research topics of 'Thyroid cancer: Advances in diagnostic research'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver